Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 11

Trial Status

Completed1

Role Distribution

Principal Investigator1
PI Rate100%

Activity Timeline

Clinical Trials (1)

NCT00363272Phase 1Completed
Ispinesib in Treating Young Patients With Relapsed or Refractory Solid Tumors or Lymphoma
Childhood Burkitt LymphomaChildhood Central Nervous System Germ Cell TumorChildhood Choroid Plexus Tumor+22 more
Principalinvestigator

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Maryam Fouladi

Children's Oncology Group

Related
5 trials

Shared therapeutic areas:

Recurrent Childhood MedulloblastomaRecurrent Childhood Supratentorial Primitive Neuroectodermal TumorUnspecified Childhood Solid Tumor, Protocol Specific+21 more

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score29%

Amar Gajjar

Pediatric Brain Tumor Consortium

Related
4 trials

Shared therapeutic areas:

Recurrent Childhood MedulloblastomaChildhood Central Nervous System Germ Cell TumorChildhood Choroid Plexus Tumor+14 more

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score20%

M. Sue O'Dorisio, MD, PhD

University of Iowa

Related
4 trials

Shared therapeutic areas:

Childhood Choroid Plexus TumorChildhood CraniopharyngiomaChildhood Grade I Meningioma+13 more

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score19%

David Maloney

Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium

Related
11 trials

Shared therapeutic areas:

Childhood Burkitt LymphomaRecurrent Childhood Grade III Lymphomatoid GranulomatosisRecurrent Childhood Large Cell Lymphoma+2 more

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score6%

Brenda Sandmaier

Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium

Related
12 trials

Shared therapeutic areas:

Recurrent Childhood Lymphoblastic LymphomaChildhood Burkitt LymphomaRecurrent Childhood Large Cell Lymphoma+2 more

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score6%

Hongtao Liu

University of Chicago Comprehensive Cancer Center

Related
4 trials

Shared therapeutic areas:

Childhood Burkitt LymphomaRecurrent Childhood Grade III Lymphomatoid GranulomatosisRecurrent Childhood Large Cell Lymphoma+2 more

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score6%

Marco Mielcarek

Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium

Related
5 trials

Shared therapeutic areas:

Childhood Burkitt LymphomaRecurrent Childhood Grade III Lymphomatoid GranulomatosisRecurrent Childhood Large Cell Lymphoma+2 more

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score6%

Leona Holmberg

Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium

Related
7 trials

Shared therapeutic areas:

Recurrent Childhood Large Cell LymphomaRecurrent Childhood Lymphoblastic LymphomaRecurrent Childhood Small Noncleaved Cell Lymphoma

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score4%

Lars M. Wagner, MD

Children's Hospital Medical Center, Cincinnati

Related
3 trials

Shared therapeutic areas:

Unspecified Childhood Solid Tumor, Protocol Specific

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score1%

Bryan Oronsky, MD

EpicentRx, Inc.

Related
4 trials

Shared therapeutic areas:

Unspecified Childhood Solid Tumor, Protocol Specific
Similarity Score1%

Publications (0)

No publications found for this investigator.

Clinical Trials (1)

Showing 1 of 1 trials

NCT00363272Phase 1PrincipalInvestigator

Ispinesib in Treating Young Patients With Relapsed or Refractory Solid Tumors or Lymphoma

Childhood Burkitt LymphomaChildhood Central Nervous System Germ Cell TumorChildhood Choroid Plexus Tumor+22 more
Completed

All 1 trials loaded